A culturally tailored personaliseD nutrition intErvention in South ASIan women at risk of Gestational Diabetes Mellitus (DESI-GDM): a randomised controlled trial protocol

Author:

Stennett Rosain NORCID,Adamo Kristi B,Anand Sonia SORCID,Bajaj Harpreet S,Bangdiwala Shrikant IORCID,Desai Dipika,Gerstein Hertzel CORCID,Kandasamy SujaneORCID,Khan Farah,Lear Scott AORCID,McDonald Sarah D,Pocsai Tayler,Ritvo PaulORCID,Rogge Andrea,Schulze Karleen MORCID,Sherifali DianaORCID,Stearns Jennifer C,Wahi Gita,Williams Natalie C,Zulyniak Michael AORCID,de Souza Russell JORCID

Abstract

IntroductionSouth Asians are more likely to develop gestational diabetes mellitus (GDM) than white Europeans. Diet and lifestyle modifications may prevent GDM and reduce undesirable outcomes in both the mother and offspring. Our study seeks to evaluate the effectiveness and participant acceptability of a culturally tailored, personalised nutrition intervention on the glucose area under the curve (AUC) after a 2-hour 75 g oral glucose tolerance test (OGTT) in pregnant women of South Asian ancestry with GDM risk factors.Methods and analysisA total of 190 South Asian pregnant women with at least 2 of the following GDM risk factors—prepregnancy body mass index>23, age>29, poor-quality diet, family history of type 2 diabetes in a first-degree relative or GDM in a previous pregnancy will be enrolled during gestational weeks 12–18, and randomly assigned in a 1:1 ratio to: (1) usual care, plus weekly text messages to encourage walking and paper handouts or (2) a personalised nutrition plan developed and delivered by a culturally congruent dietitian and health coach; and FitBit to track steps. The intervention lasts 6–16 weeks, depending on week of recruitment. The primary outcome is the glucose AUC from a three-sample 75 g OGTT 24–28 weeks’ gestation. The secondary outcome is GDM diagnosis, based on Born-in-Bradford criteria (fasting glucose>5.2 mmol/L or 2 hours post load>7.2 mmol/L).Ethics and disseminationThe study has been approved by the Hamilton Integrated Research Ethics Board (HiREB #10942). Findings will be disseminated among academics and policy-makers through scientific publications along with community-orientated strategies.Trial registration numberNCT03607799.

Funder

The Canadian Institutes of Health Research

Hamilton Health Sciences

Population Health Research Institute

Publisher

BMJ

Subject

General Medicine

Reference74 articles.

1. National Institute of Diabetes and Digestive and Kidney Diseases . Gestational diabetes 2017. n.d. Available: https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/gestational

2. Hyperglycemia and Adverse Pregnancy Outcomes

3. National Institute for Health and Care Excellence . Diabetes in pregnancy: management from preceonception to the postnatal period london, UK2018. n.d. Available: https://www.nice.org.uk/guidance/ng3/chapter/2-research-recommendations#postnatal-treatment-for-women-diagnosed-with-gestational-diabetes

4. Gestational Diabetes Mellitus: Clinical Predictors and Long-Term Risk of Developing Type 2 Diabetes

5. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3